Application no. and date | 15712241.7 (espacenet) (Federated) (European Patent Register), 20150313 | Patent/reg. no. and date | DK/EP 3119810, 20240228 | Publication date | 20170125 | Priority no. and date | US 201461954094 P, 20140317, US 201462025400 P, 20140716, US 201462043182 P, 20140828, EP 15305293, 20150226 | EP pub. no. and date |
EP 3119810 20170125 | Effective date | | Applicant/owner | Sanofi Biotechnology, 82 Avenue Raspail
94250 Gentilly, FR | Applicant ref. no. | | Inventor | BESSAC, Laurence, c/o Sanofi, 54 rue La Boétie
75008 Paris, FR, HANOTIN, Corinne, c/o Sanofi, 54 rue La Boétie
75008 Paris, FR, PORDY, Robert, C., c/o Regeneron Pharmaceuticals, INC., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US, SASIELA, William, J., c/o Regeneron Pharmaceuticals, INC., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US, SCHWARTZ, Gregory, G., c/o Va Medical Center, Cardiology Section, 1055 Clermont Street (111B),
Denver, CO 80220, US, STEG, Philippe Gabriel, Université Paris Diderot and Cardiology Department, Centre Hospitalier Bichat, Assistance Publique Hopitaux de Paris, 46 rue Henri Huchard
75877 Paris Cedex 18, FR | Representative | | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 9/00 (2006.01) , C07K 16/40 (2006.01) | Title | METHODS FOR REDUCING CARDIOVASCULAR RISK | Int. application no. | US2015020564 | Int. publication no. | WO2015142668 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|